Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04647851 · ClinicalTrials.gov registry record · NA

Remote Exercise Study for Individuals With Down Syndrome

A NA study, sponsored by University of Nevada, Las Vegas.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT04647851: Completed NA study, sponsored by University of Nevada, Las Vegas.

NCT04647851 is a NA study that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04647851, a NA study, has completed, sponsored by University of Nevada, Las Vegas.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This pilot study aims to test whether remote delivery of the exercise intervention provides a sufficient training stimulus. This pilot study will be remote and online-only, and will have no in-person interaction, data collection or intervention. 20 Participants will participate in a 12-wk, 3hrs/wk remote exercise intervention and in a pre- and a posttest remote testing session. We will use Zoom for all testing and exercise sessions.

Primary Outcome

We measure aerobic endurance with the 2-min Step Test, outcome measure is number of times the right leg is lifted.

Interventions

  • OTHER Remote exercise intervention Down syndrome

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2020-11-18
Est. Completion 2022-12-31
Phase NA
University of Nevada, Las Vegas

52 total trials

What the finished NCT04647851 record still lists

NCT04647851 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Remote exercise intervention Down syndrome is the first listed.

NCT04647851 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04647851 about?

NCT04647851 is a clinical study titled "Remote Exercise Study for Individuals With Down Syndrome". This pilot study aims to test whether remote delivery of the exercise intervention provides a sufficient training stimulus. This pilot study will be remote and online-only, and will have no in-person interaction, data collection or intervention. 20 Participants will participate in a 12-wk, 3hrs/wk r...

What is the current status of trial NCT04647851?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-11-18. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT04647851?

The interventions under investigation include: Remote exercise intervention Down syndrome (OTHER).

Who is sponsoring clinical trial NCT04647851?

This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04647851's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04647851, the US trial registry maintained by the National Library of Medicine. NCT04647851 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.